AI assistant
PULSE BIOSCIENCES, INC. — Director's Dealing 2025
Jun 17, 2025
32093_dirs_2025-06-16_b7398313-5054-4ef6-9123-649c3ff9b21c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-06-12
Reporting Person: UECKER DARRIN (Director, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-12 | Common Stock | S | 15000 | $16.40 | Disposed | 137872 | Direct |
| 2025-06-13 | Common Stock | S | 15000 | $15.98 | Disposed | 122872 | Direct |
Footnotes
F1: The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.32 to $16.57 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
F2: The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.90 to $16.04 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.